| Autor: |
Bradshaw JM; Principia Biopharma, South San Francisco, California, USA., McFarland JM; Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California, USA., Paavilainen VO; Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California, USA., Bisconte A; Principia Biopharma, South San Francisco, California, USA., Tam D; Principia Biopharma, South San Francisco, California, USA., Phan VT; Principia Biopharma, South San Francisco, California, USA., Romanov S; Nanosyn Inc., Santa Clara, California, USA., Finkle D; Principia Biopharma, South San Francisco, California, USA., Shu J; Principia Biopharma, South San Francisco, California, USA., Patel V; Principia Biopharma, South San Francisco, California, USA., Ton T; Principia Biopharma, South San Francisco, California, USA., Li X; Principia Biopharma, South San Francisco, California, USA., Loughhead DG; Principia Biopharma, South San Francisco, California, USA., Nunn PA; Principia Biopharma, South San Francisco, California, USA., Karr DE; Principia Biopharma, South San Francisco, California, USA., Gerritsen ME; Principia Biopharma, South San Francisco, California, USA., Funk JO; Principia Biopharma, South San Francisco, California, USA., Owens TD; Principia Biopharma, South San Francisco, California, USA., Verner E; Principia Biopharma, South San Francisco, California, USA., Brameld KA; Principia Biopharma, South San Francisco, California, USA., Hill RJ; Principia Biopharma, South San Francisco, California, USA., Goldstein DM; Principia Biopharma, South San Francisco, California, USA., Taunton J; Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California, USA. |
